Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Scheid

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
The Cochrane Database of Systematic Reviews|May 2, 2024
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplantPeter Langer, Lukas John, Ina Monsef, et al.
European Journal of Haematology|September 29, 2020
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims databaseChristof Scheid, Igor W Blau, Leopold Sellner, et al.
Deutsches Arzteblatt International|March 22, 2022
Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined SignificanceVanessa Piechotta, Nicole Skoetz, Monika Engelhardt, et al.
The Cochrane Database of Systematic Reviews|November 7, 2024
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsSinje Kiene, Melanie Albrecht, Sebastian Theurich, et al.
Current Stem Cell Research & Therapy|June 9, 2009
The use of statins in hematopoietic stem cell transplantationAlexander Shimabukuro-Vornhagen, Jan Glossmann, Tanja Liebig, et al.
Bone Marrow Transplantation|May 30, 2025
The effect of posttransplant cyclophosphamide on ocular graft-versus-host diseaseLeonie Menghesha, Volkan Tahmaz, Udo Holtick, et al.
American Journal of Hematology|September 28, 2002
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabJens Chemnitz, Andreas Draube, Christof Scheid, et al.
Drugs - Real World Outcomes|July 2, 2022
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data AnalysisChristof Scheid, Robert Kudernatsch, Marie Eckart, et al.
Experimental Hematology|December 17, 2002
Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndromeIrith Baumann, Christof Scheid, Mauro Santibanez Koref, et al.
Hemasphere|July 2, 2026
Transitioning CAR-T therapy for multiple myeloma to the outpatient setting: First clinical insights with cilta-cel in GermanyChristof Scheid, Philipp Gödel, Christopher Krone, et al.
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
The Cochrane Database of Systematic Reviews|May 2, 2024
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplantPeter Langer, Lukas John, Ina Monsef, et al.
European Journal of Haematology|September 29, 2020
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims databaseChristof Scheid, Igor W Blau, Leopold Sellner, et al.
Deutsches Arzteblatt International|March 22, 2022
Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined SignificanceVanessa Piechotta, Nicole Skoetz, Monika Engelhardt, et al.
The Cochrane Database of Systematic Reviews|November 7, 2024
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsSinje Kiene, Melanie Albrecht, Sebastian Theurich, et al.
Current Stem Cell Research & Therapy|June 9, 2009
The use of statins in hematopoietic stem cell transplantationAlexander Shimabukuro-Vornhagen, Jan Glossmann, Tanja Liebig, et al.
Bone Marrow Transplantation|May 30, 2025
The effect of posttransplant cyclophosphamide on ocular graft-versus-host diseaseLeonie Menghesha, Volkan Tahmaz, Udo Holtick, et al.
American Journal of Hematology|September 28, 2002
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximabJens Chemnitz, Andreas Draube, Christof Scheid, et al.
Drugs - Real World Outcomes|July 2, 2022
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data AnalysisChristof Scheid, Robert Kudernatsch, Marie Eckart, et al.
Experimental Hematology|December 17, 2002
Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndromeIrith Baumann, Christof Scheid, Mauro Santibanez Koref, et al.
Hemasphere|July 2, 2026
Transitioning CAR-T therapy for multiple myeloma to the outpatient setting: First clinical insights with cilta-cel in GermanyChristof Scheid, Philipp Gödel, Christopher Krone, et al.
Pageof 20